What I Do and Why: HBV Treatment Strategies for Diverse Patient Populations

Featuring interactive multimedia modules, downloadable slidesets, and expert-authored ClinicalThought commentaries from US and European faculty, this program explores in depth why leading experts make specific HBV management decisions in their own practices and equips learners with key strategies for treating a diverse array of patients.
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Program Director
person default
Joseph Ahn, MD, MS, MBA
Maria Buti, MD
Anna Christina L. dela Cruz, MD
Steven L. Flamm, MD
person default
Pietro Lampertico, MD, PhD
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD



ClinicalThought

Deciding which patients with chronic hepatitis B should be treated is not as simple as determining if their ALT and DNA levels fall above guideline thresholds. Here’s my take.

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Program Director
Released: April 6, 2020

Preventing mother-to-child transmission of HBV infection is critical to ensure the long-term health of the newborn. Here’s how we can prevent infection in infants born to mothers with HBV infection.

Maria Buti, MD Released: April 29, 2020

The early detection of HCC in patients with chronic HBV infection means the difference between curable vs terminal disease. Here is how I ensure I do not miss HCC in my patients.

Steven L. Flamm, MD Released: June 16, 2020

What are the pros and cons of discontinuing oral therapy with nucleos(t)ide analogues in patients with chronic HBV infection? Here’s my take.

person default Pietro Lampertico, MD, PhD Released: July 10, 2020

How do you distinguish between patients who are true inactive carriers and those with immune active HBeAg-negative chronic hepatitis B? Here’s my take.

Anna Christina L. dela Cruz, MD Released: August 18, 2020

HBV Management in Europe

In this interactive virtual module, expert faculty discuss how they would manage complex patients with HBV infection, emphasizing European guidelines and perspectives.

Review European guideline recommendations informing HBV management strategies for complex cases and learn how expert faculty would approach each case

Maria Buti, MD person default Pietro Lampertico, MD, PhD Released: June 1, 2020

HBV Management Decisions

In this interactive virtual module, expert faculty discuss how they weigh various patient factors to aid in management decisions for patients with HBV infection; topics include treatment candidacy, individualizing treatment, patient monitoring, and approaches to immune-tolerant HBV infection.

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Program Director
Steven L. Flamm, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: July 7, 2020 Expired: July 6, 2021

Review guideline recommendations and key data on evaluating patient and disease characteristics to inform treatment candidacy and the optimal treatment approach; topics include treatment options, patient monitoring, and approaches to immune-tolerant HBV infection.

Steven L. Flamm, MD Mindie H. Nguyen, MD, MAS, AGAF, FAASLD Released: July 7, 2020

HBV Complex Cases

In this interactive virtual module, expert faculty discuss how they would manage complex patients with HBV infection based on individual patient factors and current guidelines; topics include fibrosis assessment, pregnancy, and using qHBsAg to assess inactive carrier status.

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Program Director
person default Joseph Ahn, MD, MS, MBA Anna Christina L. dela Cruz, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: July 20, 2020 Expired: July 19, 2021

Review guideline recommendations informing HBV management strategies for complex cases and learn how expert faculty would approach each case; topics include fibrosis assessment, pregnancy, and using qHBsAg to assess inactive carrier status.

person default Joseph Ahn, MD, MS, MBA Anna Christina L. dela Cruz, MD Released: July 21, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue